Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 0.2980
+0.0180 (6.43%)
May 6, 2026, 3:05 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 22.23 million as of May 6, 2026. Its market cap has decreased by -86.18% in one year.
Market Cap
22.23M
Enterprise Value
19.19M
Revenue
2.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has decreased from 35.83M to 22.23M, a decrease of -37.96%. That is a compound annual growth rate of -4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 20.88M | -85.34% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.47B |
| Orexo AB | 658.62M |
| Enzymatica AB | 616.55M |
| Dicot Pharma AB | 601.20M |
| Cinclus Pharma Holding AB | 575.21M |
| Nanexa AB | 564.53M |
| Moberg Pharma AB | 540.51M |
| Klaria Pharma Holding AB (publ.) | 215.48M |